News & Analysis on Clinical Trial Services & Contract Research And Development
Augmented reality has unlimited potential and will address the pharmaceutical industry’s need for greater control over efficiency, safety, and reliability, says Apprentice CEO.
CTI and Eurotrials have established an integration team and do not expect to lose any employees or clients on either side, says CEO.
PSI CRO has purchased new office space in Research Triangle Park (RTP) as the company expects to grow locally and globally in 2018.
Three-dimensional printing technology is attracting increased attention from the US FDA say Aprecia and Cycle, which have announced a partnership to develop 3D-printed orphan drugs.
Arrowhead Pharmaceuticals says it is looking to move six candidates into the clinic within the next year thanks to its newly unveiled RNAi delivery platform.
update - CEO: ideal model is two to four API plants and six to eight drug facilities
Teva Pharmaceutical Industries will reduce its workforce by 14,000, rejig its generics portfolio and speed up optimization of its plant network as part of a $3bn (€2.5bn) cost saving plan.
Quality system deficiencies remain the most commonly observed problem during GDP inspections according to the MHRA.
Failing to ensure third-party manufacturers operated in conformance with GMP has landed Korean OTC maker Seindni Co. Ltd a US FDA warning.